167 related articles for article (PubMed ID: 18008329)
1. HRK inactivation associated with promoter methylation and LOH in prostate cancer.
Higuchi T; Nakamura M; Shimada K; Ishida E; Hirao K; Konishi N
Prostate; 2008 Jan; 68(1):105-13. PubMed ID: 18008329
[TBL] [Abstract][Full Text] [Related]
2. Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas.
Nakamura M; Ishida E; Shimada K; Nakase H; Sakaki T; Konishi N
Acta Neuropathol; 2005 Oct; 110(4):402-10. PubMed ID: 16155764
[TBL] [Abstract][Full Text] [Related]
3. Defective expression of HRK is associated with promoter methylation in primary central nervous system lymphomas.
Nakamura M; Ishida E; Shimada K; Nakase H; Sakaki T; Konishi N
Oncology; 2006; 70(3):212-21. PubMed ID: 16809940
[TBL] [Abstract][Full Text] [Related]
4. The role of HRK gene in human cancer.
Nakamura M; Shimada K; Konishi N
Oncogene; 2008 Dec; 27 Suppl 1():S105-13. PubMed ID: 19641496
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
6. Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer.
Shiina H; Breault JE; Basset WW; Enokida H; Urakami S; Li LC; Okino ST; Deguchi M; Kaneuchi M; Terashima M; Yoneda T; Shigeno K; Carroll PR; Igawa M; Dahiya R
Cancer Res; 2005 Mar; 65(6):2130-8. PubMed ID: 15781623
[TBL] [Abstract][Full Text] [Related]
7. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K
Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369
[TBL] [Abstract][Full Text] [Related]
8. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
9. Aberrant promoter methylation of laminin-5-encoding genes in prostate cancers and its relationship to clinicopathological features.
Sathyanarayana UG; Padar A; Suzuki M; Maruyama R; Shigematsu H; Hsieh JT; Frenkel EP; Gazdar AF
Clin Cancer Res; 2003 Dec; 9(17):6395-400. PubMed ID: 14695140
[TBL] [Abstract][Full Text] [Related]
10. Close localization of DAP-kinase positive tumour-associated macrophages and apoptotic colorectal cancer cells.
Schneider-Stock R; Kuester D; Ullrich O; Mittag F; Habold C; Boltze C; Peters B; Krueger S; Hintze C; Meyer F; Hartig R; Roessner A
J Pathol; 2006 May; 209(1):95-105. PubMed ID: 16575786
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation.
Padar A; Sathyanarayana UG; Suzuki M; Maruyama R; Hsieh JT; Frenkel EP; Minna JD; Gazdar AF
Clin Cancer Res; 2003 Oct; 9(13):4730-4. PubMed ID: 14581343
[TBL] [Abstract][Full Text] [Related]
12. Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features.
Maruyama R; Toyooka S; Toyooka KO; Virmani AK; Zöchbauer-Müller S; Farinas AJ; Minna JD; McConnell J; Frenkel EP; Gazdar AF
Clin Cancer Res; 2002 Feb; 8(2):514-9. PubMed ID: 11839671
[TBL] [Abstract][Full Text] [Related]
13. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.
Wu JY; Wang J; Lai JC; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H
Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569
[TBL] [Abstract][Full Text] [Related]
14. Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumors.
Yin D; Xie D; Hofmann WK; Miller CW; Black KL; Koeffler HP
Oncogene; 2002 Nov; 21(54):8372-8. PubMed ID: 12447702
[TBL] [Abstract][Full Text] [Related]
15. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
[TBL] [Abstract][Full Text] [Related]
16. Methylation of the ASC gene promoter is associated with aggressive prostate cancer.
Collard RL; Harya NS; Monzon FA; Maier CE; O'Keefe DS
Prostate; 2006 May; 66(7):687-95. PubMed ID: 16425203
[TBL] [Abstract][Full Text] [Related]
17. Genetic and epigenetic alteration profiles for multiple genes in salivary gland carcinomas.
Kishi M; Nakamura M; Nishimine M; Ikuta M; Kirita T; Konishi N
Oral Oncol; 2005 Feb; 41(2):161-9. PubMed ID: 15695118
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations.
Segditsas S; Sieber OM; Rowan A; Setien F; Neale K; Phillips RK; Ward R; Esteller M; Tomlinson IP
Exp Mol Pathol; 2008 Dec; 85(3):201-6. PubMed ID: 18977219
[TBL] [Abstract][Full Text] [Related]
19. Detailed analysis of expression and promoter methylation status of apoptosis-related genes in prostate cancer.
Carvalho JR; Filipe L; Costa VL; Ribeiro FR; Martins AT; Teixeira MR; Jerónimo C; Henrique R
Apoptosis; 2010 Aug; 15(8):956-65. PubMed ID: 20464497
[TBL] [Abstract][Full Text] [Related]
20. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
